These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 35300833)

  • 1. Serum Low-Density Lipoprotein Cholesterol and Cardiovascular Disease Risk Across Chronic Kidney Disease Stages (Data from 1.9 Million United States Veterans).
    Hashemi L; Hsiung JT; Arif Y; Soohoo M; Jackson N; Gosmanova EO; Budoff M; Kovesdy CP; Kalantar-Zadeh K; Streja E
    Am J Cardiol; 2022 May; 170():47-55. PubMed ID: 35300833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipids, Apolipoproteins, and Risk of Atherosclerotic Cardiovascular Disease in Persons With CKD.
    Bajaj A; Xie D; Cedillo-Couvert E; Charleston J; Chen J; Deo R; Feldman HI; Go AS; He J; Horwitz E; Kallem R; Rahman M; Weir MR; Anderson AH; Rader DJ;
    Am J Kidney Dis; 2019 Jun; 73(6):827-836. PubMed ID: 30686529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of Atherosclerotic Cardiovascular Disease and Nonatherosclerotic Cardiovascular Disease Hospitalizations for Triglycerides Across Chronic Kidney Disease Stages Among 2.9 Million US Veterans.
    Soohoo M; Hashemi L; Hsiung JT; Moradi H; Budoff MJ; Kovesdy CP; Kalantar-Zadeh K; Streja E
    J Am Heart Assoc; 2021 Dec; 10(23):e022988. PubMed ID: 34729994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum triglycerides and mortality risk across stages of chronic kidney disease in 2 million U.S. veterans.
    Soohoo M; Moradi H; Obi Y; Kovesdy CP; Kalantar-Zadeh K; Streja E
    J Clin Lipidol; 2019; 13(5):744-753.e15. PubMed ID: 31562050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigating linear and nonlinear associations of LDL cholesterol with incident chronic kidney disease, atherosclerotic cardiovascular disease and all-cause mortality: A prospective and Mendelian randomization study.
    Wang Z; Xiao Y; Lu J; Zou C; Huang W; Zhang J; Liu S; Han L; Jiao F; Tian D; Jiang Y; Du X; Ma RCW; Jiang G
    Atherosclerosis; 2023 Dec; 387():117394. PubMed ID: 38029611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statins, Mortality, and Major Adverse Cardiovascular Events Among US Veterans With Chronic Kidney Disease.
    Barayev O; Hawley CE; Wellman H; Gerlovin H; Hsu W; Paik JM; Mandel EI; Liu CK; Djoussé L; Gaziano JM; Gagnon DR; Orkaby AR
    JAMA Netw Open; 2023 Dec; 6(12):e2346373. PubMed ID: 38055276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between intensity of statin therapy and mortality in persons with chronic kidney disease.
    Walther CP; Richardson PA; Virani SS; Winkelmayer WC; Navaneethan SD
    Nephrol Dial Transplant; 2020 Feb; 35(2):312-319. PubMed ID: 30053252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation of Cardiovascular Events and Deaths to Low-Density Lipoprotein Cholesterol Level Among Statin-Treated Patients With Atherosclerotic Cardiovascular Disease.
    Chamberlain AM; Cohen SS; Weston SA; Fox KM; Xiang P; Killian JM; Qian Y
    Am J Cardiol; 2019 Jun; 123(11):1739-1744. PubMed ID: 30948001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lowering Targeted Atherogenic Lipoprotein Cholesterol Goals for Patients at "Extreme" ASCVD Risk.
    Rosenblit PD
    Curr Diab Rep; 2019 Nov; 19(12):146. PubMed ID: 31754844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of lipid-lowering therapies in patients with chronic kidney disease and atherosclerotic cardiovascular disease: 2-year results from Getting to an imprOved Understanding of Low-Density lipoprotein cholesterol and dyslipidemia management (GOULD).
    Shaik A; Kosiborod M; de Lemos JA; Gao Q; Mues KE; Alam S; Bhatt DL; Cannon CP; Ballantyne CM; Rosenson RS;
    Clin Cardiol; 2022 Dec; 45(12):1303-1310. PubMed ID: 36124341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2017 Taiwan lipid guidelines for high risk patients.
    Li YH; Ueng KC; Jeng JS; Charng MJ; Lin TH; Chien KL; Wang CY; Chao TH; Liu PY; Su CH; Chien SC; Liou CW; Tang SC; Lee CC; Yu TY; Chen JW; Wu CC; Yeh HI;
    J Formos Med Assoc; 2017 Apr; 116(4):217-248. PubMed ID: 28242176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations between lower levels of low-density lipoprotein cholesterol and cardiovascular events in very high-risk patients: Pooled analysis of nine ODYSSEY trials of alirocumab versus control.
    Vallejo-Vaz AJ; Ray KK; Ginsberg HN; Davidson MH; Eckel RH; Lee LV; Bessac L; Pordy R; Letierce A; Cannon CP
    Atherosclerosis; 2019 Sep; 288():85-93. PubMed ID: 31349086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dyslipidaemia in patients with chronic kidney disease - a neglected cardiovascular risk factor.
    Essop MR; Seedat F; Raal FJ
    S Afr Med J; 2023 Nov; 113(11):35-40. PubMed ID: 38525632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Statin Use With All-Cause and Cardiovascular Mortality in US Veterans 75 Years and Older.
    Orkaby AR; Driver JA; Ho YL; Lu B; Costa L; Honerlaw J; Galloway A; Vassy JL; Forman DE; Gaziano JM; Gagnon DR; Wilson PWF; Cho K; Djousse L
    JAMA; 2020 Jul; 324(1):68-78. PubMed ID: 32633800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective examination of lipid-lowering treatment patterns in a real-world high-risk cohort in the UK in 2014: comparison with the National Institute for Health and Care Excellence (NICE) 2014 lipid modification guidelines.
    Steen DL; Khan I; Ansell D; Sanchez RJ; Ray KK
    BMJ Open; 2017 Feb; 7(2):e013255. PubMed ID: 28213597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation of First and Total Recurrent Atherosclerotic Cardiovascular Disease Events to Increased Lipoprotein(a) Levels Among Statin Treated Adults With Cardiovascular Disease.
    Wong ND; Zhao Y; Sung J; Browne A
    Am J Cardiol; 2021 Apr; 145():12-17. PubMed ID: 33454339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Association Between Low-Density Lipoprotein Cholesterol and Incident Atherosclerotic Cardiovascular Disease in Older Adults: Results From the National Institutes of Health Pooled Cohorts.
    Nanna MG; Navar AM; Wojdyla D; Peterson ED
    J Am Geriatr Soc; 2019 Dec; 67(12):2560-2567. PubMed ID: 31411740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic kidney disease and statin eligibility.
    Vega GL; Wang J; Grundy SM
    J Clin Lipidol; 2021; 15(1):173-180. PubMed ID: 33191195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-density lipoprotein cholesterol response after statin initiation among persons living with human immunodeficiency virus.
    Burkholder GA; Muntner P; Zhao H; Mugavero MJ; Overton ET; Kilgore M; Drozd DR; Crane HM; Moore RD; Mathews WC; Geng E; Boswell S; Floris-Moore M; Rosenson RS
    J Clin Lipidol; 2018; 12(4):988-998.e5. PubMed ID: 29853312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolving Management of Low-Density Lipoprotein Cholesterol: A Personalized Approach to Preventing Atherosclerotic Cardiovascular Disease Across the Risk Continuum.
    Wilkinson MJ; Lepor NE; Michos ED
    J Am Heart Assoc; 2023 Jun; 12(11):e028892. PubMed ID: 37260036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.